(HealthDay)—Phosphodiesterase type 5 inhibitor use after radical prostatectomy is associated with increased risk of biochemical recurrence, according to a study published in the February issue of The Journal of Urology.
Jan 29, 2015
0
6
(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed a recent guideline for adjuvant and salvage radiotherapy after prostatectomy. The endorsement was published online Nov. 3 in the Journal of Clinical ...
Nov 6, 2014
0
0
(HealthDay)—From 2003 to 2010 there was widespread adoption of robot-assisted radical prostatectomy (RARP), especially among high-volume surgeons, according to a study published online Aug. 26 in BJU International.
Sep 5, 2014
0
0
Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 – the peak year that teaching hospitals nationwide embraced the pursuit of minimally ...
Jul 2, 2014
0
0
(HealthDay)—The open market cost of a radical prostatectomy (RP) varies widely in U.S. hospitals, according to research published in the March issue of Urology.
Jun 18, 2014
0
0
Men whose prostate-specific antigen (PSA) level increases after radical prostatectomy or radiotherapy but who have no known metastases comprise the second-largest group of patients with prostate cancer. However, no standard ...
Jun 13, 2014
0
0
(HealthDay)—Claims of not receiving proper informed consent and clinical performance are the main issues that arise in radical prostatectomy malpractice litigation, according to a study published in the June issue of The ...
May 29, 2014
0
0
Minimally invasive robot-assisted surgery, which has become the main choice for surgically removing cancerous prostate glands during recent years, is as safe as open surgery for Medicare patients over age 65.
May 19, 2014
0
0
Men with blood group O are far less likely to suffer a recurrence of cancer after prostate tumour surgery than men with other blood types, researchers reported on Monday.
Apr 14, 2014
0
1
More than 230,000 men will be diagnosed with prostate cancer this year in the United States, but determining their course of treatment remains a source of considerable debate. A new study by researchers from Uppsala University ...
Mar 5, 2014
0
0
